Zynerba Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer
Sep 13, 2016 20:05 pm UTC| Business
DEVON, Pa., Sept. 13, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today...
Sep 13, 2016 20:05 pm UTC| Business
PITTSBURGH, Sept. 13, 2016 -- II‐VI Incorporated (NASDAQ:IIVI), the leading provider of embedded monitoring in optical networks today announced that Dr. Sanjai Parthasarathi, Vice President of Product Marketing and...
Sep 13, 2016 20:02 pm UTC| Business
BURNABY, British Columbia, Sept. 13, 2016 -- Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that the underwriters of the previously announced public offering of its...
Vital Therapies Provides Corporate Update
Sep 13, 2016 20:01 pm UTC| Business
SAN DIEGO, Sept. 13, 2016 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today provided a corporate...
Avinger Signs Agreement with U.S. Department of Veterans Affairs for Lumivascular Technology
Sep 13, 2016 20:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 13, 2016 -- Avinger, Inc. (NASDAQ:AVGR), a developer of innovative treatments for peripheral artery disease (PAD), today announced the company has received an FSS Contract Award from the U.S....
Blue Hills Bancorp Provides Update on Problem Loans and Announces Third Share Repurchase Program
Sep 13, 2016 20:00 pm UTC| Business
NORWOOD, Mass., Sept. 13, 2016 -- Blue Hills Bancorp (Nasdaq:BHBK) today announced an update on problem loans to one commercial customer. As previously disclosed in the Company’s Quarterly Report on Form 10-Q for the...
Artisan Partners Asset Management Inc. Mourns Death of Executive Vice President Dean Patenaude
Sep 13, 2016 19:44 pm UTC| Business
MILWAUKEE, Sept. 13, 2016 -- Artisan Partners Asset Management Inc. (NYSE:APAM) sadly announced today that Executive Vice President Dean Patenaude passed away as a result of a sudden and unexpected stroke on September...